Ilex Medical Ltd (ILX.TA)
ILA 6040.0
(-4.22%)
ILA 6040.0
(-4.22%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 392.6 Million ILS | 37.24% |
| 2022 | 286.07 Million ILS | -4.48% |
| 2021 | 299.49 Million ILS | -10.79% |
| 2020 | 335.7 Million ILS | 29.93% |
| 2019 | 258.37 Million ILS | 7.71% |
| 2018 | 239.88 Million ILS | 9.66% |
| 2017 | 218.76 Million ILS | -9.99% |
| 2016 | 243.04 Million ILS | -4.92% |
| 2015 | 255.61 Million ILS | -15.34% |
| 2014 | 301.94 Million ILS | -5.69% |
| 2013 | 320.16 Million ILS | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 377.72 Million ILS | -3.79% |
| 2024 Q2 | 368.95 Million ILS | -2.32% |
| 2023 Q1 | 308.05 Million ILS | 7.68% |
| 2023 FY | 392.6 Million ILS | 37.24% |
| 2023 Q3 | 346.71 Million ILS | -2.71% |
| 2023 Q4 | 392.6 Million ILS | 13.24% |
| 2023 Q2 | 356.38 Million ILS | 15.69% |
| 2022 Q3 | 263.18 Million ILS | 2.42% |
| 2022 Q4 | 286.07 Million ILS | 8.7% |
| 2022 FY | 286.07 Million ILS | -4.48% |
| 2022 Q1 | 343.25 Million ILS | 14.61% |
| 2022 Q2 | 256.96 Million ILS | -25.14% |
| 2021 Q2 | 285.68 Million ILS | -28.47% |
| 2021 Q1 | 399.38 Million ILS | 18.97% |
| 2021 FY | 299.49 Million ILS | -10.79% |
| 2021 Q4 | 299.49 Million ILS | -8.52% |
| 2021 Q3 | 327.4 Million ILS | 14.6% |
| 2020 Q1 | 275.21 Million ILS | 6.52% |
| 2020 FY | 335.7 Million ILS | 29.93% |
| 2020 Q4 | 335.7 Million ILS | 1.67% |
| 2020 Q3 | 330.18 Million ILS | 1.59% |
| 2020 Q2 | 325 Million ILS | 18.09% |
| 2019 FY | 258.37 Million ILS | 7.71% |
| 2019 Q4 | 258.37 Million ILS | 2.06% |
| 2019 Q2 | 253.12 Million ILS | -15.36% |
| 2019 Q1 | 299.04 Million ILS | 24.66% |
| 2019 Q3 | 253.16 Million ILS | 0.01% |
| 2018 FY | 239.88 Million ILS | 9.66% |
| 2018 Q1 | 258.43 Million ILS | 18.13% |
| 2018 Q2 | 236.19 Million ILS | -8.61% |
| 2018 Q3 | 219.36 Million ILS | -7.12% |
| 2018 Q4 | 239.88 Million ILS | 9.36% |
| 2017 Q1 | 237.25 Million ILS | -2.38% |
| 2017 Q2 | 249.46 Million ILS | 5.15% |
| 2017 Q3 | 220.68 Million ILS | -11.54% |
| 2017 Q4 | 218.76 Million ILS | -0.87% |
| 2017 FY | 218.76 Million ILS | -9.99% |
| 2016 Q2 | 252.1 Million ILS | -5.75% |
| 2016 Q4 | 243.04 Million ILS | 0.19% |
| 2016 FY | 243.04 Million ILS | -4.92% |
| 2016 Q3 | 242.58 Million ILS | -3.78% |
| 2016 Q1 | 267.47 Million ILS | 4.64% |
| 2015 Q4 | 255.61 Million ILS | 1.37% |
| 2015 Q2 | 270.64 Million ILS | -5.4% |
| 2015 Q1 | 286.1 Million ILS | -5.25% |
| 2015 FY | 255.61 Million ILS | -15.34% |
| 2015 Q3 | 252.16 Million ILS | -6.83% |
| 2014 Q2 | 282.7 Million ILS | -2.47% |
| 2014 Q3 | 275.83 Million ILS | -2.43% |
| 2014 Q4 | 301.94 Million ILS | 9.47% |
| 2014 Q1 | 289.87 Million ILS | -9.46% |
| 2014 FY | 301.94 Million ILS | -5.69% |
| 2013 Q4 | 320.16 Million ILS | 2.61% |
| 2013 FY | 320.16 Million ILS | 0.0% |
| 2013 Q1 | 328.65 Million ILS | 0.0% |
| 2013 Q2 | 316.66 Million ILS | -3.65% |
| 2013 Q3 | 312.03 Million ILS | -1.46% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|